United Therapeutics Shares (Basic) decreased by 0.7% to 43.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from 44.9M to 43.5M.
Changes reflect share buybacks (decrease) or equity issuance (increase), which impact the per-share earnings calculation.
The average number of common shares outstanding during the reporting period, calculated by weighting the number of share...
Standard metric for all public companies; reflects capital structure and share repurchase activity.
weighted_shares_basic| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 44.8M | 44.9M | 45.2M | 45.4M | 45.5M | 46.3M | 46.9M | 46.9M | 47M | 44.4M | 44.6M | 44.9M | 45.1M | 43.8M | 43.5M |
| QoQ Change | — | +0.2% | +0.7% | +0.4% | +0.2% | +1.8% | +1.3% | +0.0% | +0.2% | -5.5% | +0.5% | +0.7% | +0.4% | -2.9% | -0.7% |
| YoY Change | — | — | — | +1.3% | +1.3% | +2.4% | +3.3% | +3.1% | +1.5% | -5.3% | -4.9% | -4.5% | +1.6% | -1.8% | -3.1% |